Literature DB >> 18620647

[Flu vaccination as a cardiovascular preventive measure: widely overlooked].

Germán Schwarz Chávarri, Francisco José Beltrán Riquelme, María José Nieto Sánchez, Víctor Pedrera Carbonell.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18620647      PMCID： PMC7659844          DOI： 10.1157/13124138

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  5 in total

1.  Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Carolyn B Bridges; Scott A Harper; Keiji Fukuda; Timothy M Uyeki; Nancy J Cox; James A Singleton
Journal:  MMWR Recomm Rep       Date:  2003-04-25

2.  AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.

Authors:  Sidney C Smith; Jerilyn Allen; Steven N Blair; Robert O Bonow; Lawrence M Brass; Gregg C Fonarow; Scott M Grundy; Loren Hiratzka; Daniel Jones; Harlan M Krumholz; Lori Mosca; Richard C Pasternak; Thomas Pearson; Marc A Pfeffer; Kathryn A Taubert
Journal:  Circulation       Date:  2006-05-16       Impact factor: 29.690

3.  [Preventive cardiovascular recommendations].

Authors:  A Maiques Galán; F Villar Alvarez; C Brotons Cuixart; J Torcal Laguna; D Orozco-Beltrán; J Navarro Pérez; J M Lobos-Bejarano; J R Banegas Banegas; R Ortega Sánchez-Pinilla; V Gil Guillén; P Solana Saura
Journal:  Aten Primaria       Date:  2007-11       Impact factor: 1.137

4.  Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981.

Authors:  W P Glezen; M Decker; D M Perrotta
Journal:  Am Rev Respir Dis       Date:  1987-09

5.  Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly.

Authors:  Joan Puig-Barberà; Javier Díez-Domingo; Angel Belenguer Varea; Germán Schwarz Chavarri; José A Lluch Rodrigo; Santiago Pérez Hoyos; David González Vidal
Journal:  Vaccine       Date:  2007-09-04       Impact factor: 3.641
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.